Theriva Biologics, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Theriva Biologics, Inc. (TOVX) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$2.90 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2023-03-30
- Theriva Biologics, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was -$2.90M.
- Theriva Biologics, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2021 was -$3.01M.
- Theriva Biologics, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2020 was -$3.93M.
- Theriva Biologics, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2019 was -$3.10M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2022-12-31 | -$2.90M 10-K · filed 2023-03-30 | |
| 2021-12-31 | -$3.01M 10-K · filed 2023-03-30 | |
| 2020-12-31 | -$3.93M 10-K · filed 2022-03-16 | |
| 2019-12-31 | -$3.10M 10-K · filed 2021-03-04 | |
| 2018-12-31 | -$4.22M 10-K · filed 2020-02-20 | |
| 2017-12-31 | $12.11M 10-K · filed 2019-02-27 | |
| 2016-12-31 | -$14.73M 10-K · filed 2018-02-22 | $14.73M 10-K · filed 2017-03-02 |
| 2015-12-31 | $14.07M 10-K · filed 2017-03-02 | |
| 2014-12-31 | $7.63M 10-K · filed 2016-03-10 | |
| 2013-12-31 | $4.16M 10-K · filed 2015-03-16 | -$4.16M 10-K · filed 2014-03-31 |
| 2012-12-31 | $5.96M 10-K · filed 2015-03-16 | |
| 2011-12-31 | $2.04M 10-K · filed 2013-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |